Up a level |
Arch, BN ORCID: 0000-0001-6060-8091, Kovacs, D, Scott, JT ORCID: 0000-0001-8030-5223, Jones, AP ORCID: 0000-0001-5253-730X, Harrison, EM ORCID: 0000-0002-5018-3066, Rosala-Hallas, A ORCID: 0000-0001-8012-9995, Gamble, CG ORCID: 0000-0002-3021-1955, Openshaw, PJM ORCID: 0000-0002-7220-2555, Baillie, JK ORCID: 0000-0001-5258-793X and Semple, MG ORCID: 0000-0001-9700-0418
(2021)
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study.
[Preprint]
Arch, BN ORCID: 0000-0001-6060-8091, Blair, J, Mckay, A ORCID: 0000-0003-1312-8911, Gregory, JW, Newland, P and Gamble, C ORCID: 0000-0002-3021-1955
(2017)
Response to letter to editor: 'Comment on Arch et al., <i>Trials</i>. 2016;17:517'.
TRIALS, 18 (1).
242-.